Clinical Laserthermia Systems AB (publ)

OM:CLS UR B 주식 보고서

시가총액: SEK 22.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Clinical Laserthermia Systems 미래 성장

Future 기준 확인 2/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Clinical Laserthermia Systems.

주요 정보

56.9%

수익 성장률

50.0%

EPS 성장률

Medical Equipment 수익 성장27.0%
매출 성장률56.5%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트24 Feb 2023

최근 미래 성장 업데이트

업데이트 없음

Recent updates

업데이트 없음

수익 및 매출 성장 예측

OM:CLS UR B - 애널리스트의 미래 추정치 및 과거 재무 데이터 (SEK Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/2025115-2N/AN/A1
12/31/202444-45-48-451
12/31/202317-70-70-671
3/31/20236-78-71-68N/A
12/31/20226-71-69-68N/A
9/30/20223-81-81-81N/A
6/30/20222-63-66-66N/A
3/31/20222-68-71-71N/A
12/31/20212-64-67-66N/A
9/30/20211-60-63-63N/A
6/30/20212-57-55-55N/A
3/31/20212-47-41-41N/A
12/31/20201-58-56-55N/A
9/30/20201-58-54-53N/A
6/30/20202-57-54-54N/A
3/31/20206-54-52-52N/A
12/31/20196-43-39-39N/A
9/30/20196-38-37-36N/A
6/30/20195-37-35-34N/A
3/31/20191-41-44-43N/A
12/31/20188-33-41-39N/A
9/30/201810-28-33-31N/A
6/30/201811-24-33-31N/A
3/31/201812-15-29-24N/A
12/31/20178-21-29-24N/A
9/30/20178-22-34-29N/A
6/30/20178-26-28-24N/A
3/31/20176-27-24-23N/A
12/31/20164-27N/A-20N/A
9/30/20161-27N/A-19N/A
6/30/20160-23N/A-22N/A
3/31/20160-20N/A-17N/A
12/31/2015N/A-17N/A-19N/A
9/30/20150-21N/A-21N/A
6/30/20150-20N/A-20N/A
3/31/20150-20N/A-19N/A
12/31/2014N/A-18N/A-16N/A
9/30/20140-16N/A-18N/A
6/30/2014N/A-16N/A-18N/A
3/31/2014N/A-17N/A-17N/A
12/31/2013N/A-18N/A-18N/A
9/30/20130-16N/A-13N/A
6/30/2013N/A-15N/A-12N/A
3/31/20130-13N/A-11N/A
12/31/2012N/A-13N/A-12N/A
9/30/20120-11N/A-10N/A

애널리스트 미래 성장 예측

수입 대 저축률: CLS UR B is forecast to remain unprofitable over the next 3 years.

수익 vs 시장: CLS UR B is forecast to remain unprofitable over the next 3 years.

고성장 수익: CLS UR B is forecast to remain unprofitable over the next 3 years.

수익 대 시장: CLS UR B's revenue (56.5% per year) is forecast to grow faster than the Swedish market (5.5% per year).

고성장 수익: CLS UR B's revenue (56.5% per year) is forecast to grow faster than 20% per year.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: Insufficient data to determine if CLS UR B's Return on Equity is forecast to be high in 3 years time


성장 기업 발견